Casandra
Casandra Test Code QD28335Version 1 (DRAFT)
Performing Lab
MDMA/MDA, Quantitative, Urine
Also known as: EVE, Ecstasy
Clinical Use
Order TestUse
This test is designed to detect the use of the stimulant/hallucinogen Methylenedioxymethamphetamine (MDMA, XTC, Ecstasy) and its metabolite Methylenedioxyamphetamine (MDA).
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
MDA
AnalyteQuantitation of MDA
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
MDEA
AnalyteQuantitation of MDEA
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
MDMA
AnalyteQuantitation of MDMA
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
20 mL random urine
Minimum Volume
5 mL random urine
Container
Plastic, leak‑proof urine container / sterile container
Collection Instructions
Random urine collected in plastic, leak‑proof urine container
Causes for Rejection
Preserved urine
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Similar Tests
Other tests from different labs that may be relevant
MDMA, Screen Only, Urine
Labcorp
MDMA, Screen and Confirmation, Urine
Labcorp
MDMA Confirmation (Labcorp MedWatch®)
Labcorp
Mephedrone, MDPV and Methylone, Urine
Mayo Clinic Lab
Mephedrone, MDPV, and Methylone, Screen and Confirmation, Urine
Labcorp
Methaqualone Quantitative, Urine
ARUP Laboratories
Methadone and Metabolite, Urine, Quantitative
ARUP Laboratories